scispace - formally typeset
A

Arnold L. Demain

Researcher at Drew University

Publications -  425
Citations -  21576

Arnold L. Demain is an academic researcher from Drew University. The author has contributed to research in topics: Streptomyces clavuligerus & Clostridium thermocellum. The author has an hindex of 66, co-authored 424 publications receiving 20140 citations. Previous affiliations of Arnold L. Demain include Massachusetts Institute of Technology & Merck & Co..

Papers
More filters
Journal ArticleDOI

ATP and adenylate enegry charge during phosphate-mediated control of antibiotic synthesis

TL;DR: The addition of inorganic phosphate or guanosine-5′-monophosphate to a phosphate-limited mycelial system of Streptomyces griseus inhibited candicidin production and Adenylate energy charge increased only slightly indicating that ATP is a more likely intracellular effector than energy charge in mediating phosphate control of antibiotic biosynthesis.
Journal ArticleDOI

Lysine control of penicillin biosynthesis

TL;DR: The known diminution in penicillin formation by added lysine is thought to occur via feedback regulation of the lysin biosynthetic pathway, thus depleting the cells of α-aminoadipic acid, a precur...
Journal ArticleDOI

Carbon source regulation of cephem antibiotic production by resting cells of Streptomyces clavuligerus and its reversal by protein synthesis inhibitors

TL;DR: The effect of utilizable carbon sources on the production of cephem antibiotics by Streptomyces clavuligerus has been studied and Glycerol, maltose and starch supported the most extensive growth.
Journal ArticleDOI

The cyclohexane moiety of rapamycin is derived from shikimic acid in Streptomyces hygroscopicus

TL;DR: It was found that 13C-shikimic acid was incorporated into the cyclohexane moiety of rapamycin, thereby establishing the shikIMic acid pathway origin of the seven-carbon starter unit.
Journal ArticleDOI

Synthesis of bacilysin by Bacillus subtilis branches from prephenate of the aromatic amino acid pathway.

TL;DR: Previously characterized mutants of Bacillus subtilis 168 were analyzed for the accumulation of the antibiotic bacilysin in culture broths and for the presence of b Bacilysin synthetase in cell extracts, suggesting that prephenate is the primary metabolic precursor of bacallysin.